انتقل إلى وضع عدم الاتصال باستخدام تطبيق Player FM !
المدونة الصوتية تستحق الاستماع
برعاية
![We Have The Receipts podcast artwork](https://cdn.player.fm/images/37350108/series/3hptiqPGSZRELxyS/32.jpg 32w, https://cdn.player.fm/images/37350108/series/3hptiqPGSZRELxyS/64.jpg 64w, https://cdn.player.fm/images/37350108/series/3hptiqPGSZRELxyS/128.jpg 128w, https://cdn.player.fm/images/37350108/series/3hptiqPGSZRELxyS/256.jpg 256w, https://cdn.player.fm/images/37350108/series/3hptiqPGSZRELxyS/512.jpg 512w)
![We Have The Receipts podcast artwork](/static/images/64pixel.png)
1 Love Is Blind S8: Pods & Sober High Thoughts with Courtney Revolution & Meg 1:06:00
#32 - The Future of Drug Affordability and Access | Peter Kolchinsky
Manage episode 425860949 series 2940551
In an era where breakthrough innovations coexist with concerns over drug affordability, Peter Kolchinsky, founder and Managing Partner at healthcare and life sciences investment manager RA Capital, joins us to shed light on the factors and paths forward.
Hercules Capital's Janice Bourque engages with Peter on his No Patient Left Behind initiative, a non-profit dedicated to making medicines affordable for everyone in America.
Topics Include:
- Overview of the "No Patient Left Behind" movement and its objectives
- Examining communication challenges within the drug industry
- The pivotal role of insurance in enabling patient access and affordability
- Strategies to maintain support for innovation amid pricing concerns
- Potential solutions to bridge the gap between innovation and affordability
Peter Kolchinsky, PhD is a founder and Managing Partner at RA Capital Management and author of The Great American Drug Deal. Peter is an active investor in and board member of publicly- and privately-held companies developing drugs, medical devices, diagnostics, and research tools. He served on the Board of Global Science and Technology for the National Academy of Sciences, is the author of The Entrepreneur’s Guide to a Biotech Startup, and frequently writes and speaks on the future of biotechnology innovation. Peter founded and serves as a Director of No Patient Left Behind, a non-profit advocate for healthcare reforms that would make today's medicines affordable to patients and promote the innovation that gives all of us hope for tomorrow. He holds a BA from Cornell University and a PhD in Virology from Harvard University.
37 حلقات
Manage episode 425860949 series 2940551
In an era where breakthrough innovations coexist with concerns over drug affordability, Peter Kolchinsky, founder and Managing Partner at healthcare and life sciences investment manager RA Capital, joins us to shed light on the factors and paths forward.
Hercules Capital's Janice Bourque engages with Peter on his No Patient Left Behind initiative, a non-profit dedicated to making medicines affordable for everyone in America.
Topics Include:
- Overview of the "No Patient Left Behind" movement and its objectives
- Examining communication challenges within the drug industry
- The pivotal role of insurance in enabling patient access and affordability
- Strategies to maintain support for innovation amid pricing concerns
- Potential solutions to bridge the gap between innovation and affordability
Peter Kolchinsky, PhD is a founder and Managing Partner at RA Capital Management and author of The Great American Drug Deal. Peter is an active investor in and board member of publicly- and privately-held companies developing drugs, medical devices, diagnostics, and research tools. He served on the Board of Global Science and Technology for the National Academy of Sciences, is the author of The Entrepreneur’s Guide to a Biotech Startup, and frequently writes and speaks on the future of biotechnology innovation. Peter founded and serves as a Director of No Patient Left Behind, a non-profit advocate for healthcare reforms that would make today's medicines affordable to patients and promote the innovation that gives all of us hope for tomorrow. He holds a BA from Cornell University and a PhD in Virology from Harvard University.
37 حلقات
كل الحلقات
×![Ventured Growth with Hercules Capital podcast artwork](/static/images/64pixel.png)
1 #36 - Building the Super App for Mealtime: Wonder's Recipe for Disrupting Meal Delivery | Kelley Morrell 46:16
![Ventured Growth with Hercules Capital podcast artwork](/static/images/64pixel.png)
1 #35 - Revolutionizing Compliance: AI's Role in Modern Finance | Erkin Adylov 35:51
![Ventured Growth with Hercules Capital podcast artwork](/static/images/64pixel.png)
1 #34 - The Evolution of Biotech Deals: From Pharma Consolidation to Innovation | Stephen Sands 47:03
![Ventured Growth with Hercules Capital podcast artwork](/static/images/64pixel.png)
1 #33 - How Corporate Venture Capital is Driving Healthcare Innovation | Vijay Patel 57:04
![Ventured Growth with Hercules Capital podcast artwork](/static/images/64pixel.png)
1 #32 - The Future of Drug Affordability and Access | Peter Kolchinsky 56:46
![Ventured Growth with Hercules Capital podcast artwork](/static/images/64pixel.png)
1 #31 - Dynamics of Venture Debt: Balancing Legal and Business Objectives | David Ephraim 26:57
![Ventured Growth with Hercules Capital podcast artwork](/static/images/64pixel.png)
1 #30 – Rise of the Business Operator: Cultivating the Ultimate Community of Tech Leaders | Casey Woo 50:50
![Ventured Growth with Hercules Capital podcast artwork](/static/images/64pixel.png)
1 #29 – Endpoints News: Predictions for Biotech in 2024 and Beyond | John Carroll 46:00
![Ventured Growth with Hercules Capital podcast artwork](/static/images/64pixel.png)
1 #28 – The Non-CFO, CFO: Executive Leadership, Acquisitions, and Serving 350 Million Users as Fandom’s CFO | Ed Lu 56:53
![Ventured Growth with Hercules Capital podcast artwork](/static/images/64pixel.png)
1 #27 – The Evolution of Biotech: Lessons From 35 Years of Early Stage Investing | Terry McGuire 34:29
![Ventured Growth with Hercules Capital podcast artwork](/static/images/64pixel.png)
1 #26 – Biotech and the Public: Breakthroughs, Drug Prices, and Public Relations | Rich Aldrich 40:59
![Ventured Growth with Hercules Capital podcast artwork](/static/images/64pixel.png)
1 #25 – From Physician to Founder: Scaling Iora Health to a $2 Billion Exit | Rushika Fernandopulle 33:19
![Ventured Growth with Hercules Capital podcast artwork](/static/images/64pixel.png)
1 #24 – Scaling up in Biotech, Raising $300M for a Single Pharma Product | Mark Hahn 31:57
![Ventured Growth with Hercules Capital podcast artwork](/static/images/64pixel.png)
1 #23 – From $3B to $29B in 7 Years, the Boom in Healthcare Technology Investment | Michael Greeley 28:48
![Ventured Growth with Hercules Capital podcast artwork](/static/images/64pixel.png)
1 #22 – Women’s Health: An Overlooked Market That’s Hot for Investors in 2023 | Elizabeth Bailey 32:39
مرحبًا بك في مشغل أف ام!
يقوم برنامج مشغل أف أم بمسح الويب للحصول على بودكاست عالية الجودة لتستمتع بها الآن. إنه أفضل تطبيق بودكاست ويعمل على أجهزة اندرويد والأيفون والويب. قم بالتسجيل لمزامنة الاشتراكات عبر الأجهزة.